Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
A single protein-rich meal (or an infusion of amino acids) is known to increase the glomerular filtration rate (GFR) for a few hours, a phenomenon known as “hyperfiltration.” It is important to understand the factors that initiate this upregulation because it becomes maladaptive in the long term. Several mediators and paracrine factors have been shown to participate in this upregulation, but they are not directly triggered by protein intake. Here, we explain how a rise in glucagon and in vasopressin secretion, directly induced by protein ingestion, might be the initial factors triggering the hepatic and renal events leading to an increase in the GFR. Their effects include metabolic actions in the liver and stimulation of sodium chloride reabsorption in the thick ascending limb. Glucagon is not only a glucoregulatory hormone. It is also important for the excretion of nitrogen end products by stimulating both urea synthesis in the liver (along with gluconeogenesis from amino acids) and urea excretion by the kidney. Vasopressin allows the concentration of nitrogenous end products (urea, ammonia, etc.) and other protein-associated wastes in a hyperosmotic urine, thus allowing a very significant water economy characteristic of all terrestrial mammals. No hyperfiltration occurs in the absence of one or the other hormone. Experimental results suggest that the combined actions of these two hormones, along with the complex intrarenal handling of urea, lead to alter the composition of the tubular fluid at the macula densa and to reduce the intensity of the signal activating the tubuloglomerular feedback control of GFR, thus allowing GFR to raise. Altogether, glucagon, vasopressin, and urea contribute to set up the best compromise between efficient urea excretion and water economy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
Lambers Heerspink, H. J., de Zeeuw, D., Wie, L., Leslie, B., & List, J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12127 · Cited by 837
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
Moe, S. M., Zidehsarai, M. P., Chambers, M. A., Jackman, L. A., Radcliffe, J. S., Trevino, L. L., Donahue, S. E., & Asplin, J. R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05040610 · Cited by 564
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Vallon, V., Rose, M., Gerasimova, M., Satriano, J., Platt, K. A., Koepsell, H., Cunard, R., Sharma, K., Thomson, S. C., & Rieg, T. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2012 · Cited by 370
Bankir, L. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00328-5 · Cited by 300
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214
Self-citationLow Water Intake and Risk for New-Onset Hyperglycemia
Roussel, R., Fezeu, L., Bouby, N., Balkau, B., Lantieri, O., Alhenc-Gelas, F., Marre, M., Bankir, L., & for the D.E.S.I.R. Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0652 · Cited by 165
Self-citationPlasma Vasopressin in Uncontrolled Diabetes Mellitus
Zerbe, R. L., Vinicor, F., & Robertson, G. L. (1979) · Diabetes · doi:10.2337/diab.28.5.503 · Cited by 158
Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver
Hems, D. A., & Whitton, P. D. (1973) · Biochemical Journal · doi:10.1042/bj1360705 · Cited by 150
Bardoux, P., Martin, H., Ahloulay, M., Schmitt, F., Bouby, N., Trinh-Trang-Tan, M.-M., & Bankir, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10397 · Cited by 138
Self-citationBardoux, P. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.3.497 · Cited by 136
Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action.
Bouby, N., Ahloulay, M., Nsegbe, E., Déchaux, M., Schmitt, F., & Bankir, L. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76842 · Cited by 116
Self-citationTHE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MAN
SPRUCE, B. A., MCCULLOCH, A. J., BURD, J., ØRSKOV, H., HEATON, A., BAYLIS, P. H., & ALBERTI, K. G. M. M. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00145.x · Cited by 114
Vasopressin and diabetes mellitus
Bankir, L., Bardoux, P., & Ahloulay, M. (2001) · Nephron · doi:10.1159/000045879 · Cited by 110
Self-citationPlasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
Velho, G., Bouby, N., Hadjadj, S., Matallah, N., Mohammedi, K., Fumeron, F., Potier, L., Bellili-Munoz, N., Taveau, C., Alhenc-Gelas, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0683 · Cited by 89
Self-citationInfluence of glucagon on GFR and on urea and electrolyte excretion: direct and indirect effects
Ahloulay, M., Dechaux, M., Laborde, K., & Bankir, L. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.2.f225 · Cited by 59
Self-citationRelation between human vasopressin 1a gene variance, fat intake, and diabetes
Enhörning, S., Leosdottir, M., Wallström, P., Gullberg, B., Berglund, G., Wirfält, E., & Melander, O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26382 · Cited by 55
Increased amino acid clearance and urea synthesis in a patient with glucagonoma.
Almdal, T. P., Heindorff, H., Bardram, L., & Vilstrup, H. (1990) · Gut · doi:10.1136/gut.31.8.946 · Cited by 49
Cited by
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
“88 These observations have been attributed to a GLP-1 – mediated inhibition of NHE3 (which assembles with DPP-4 in the proximal tubular brush border), thereby reducing proximal sodium reabsorption and GFR through activation of TGF. 51 However, acute administration of GLP-1RA left GFR unaffected in patients with T2DM w…”
InfluentialGLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
Muskiet, M. H. A., Tonneijck, L., Smits, M. M., van Baar, M. J. B., Kramer, M. H. H., Hoorn, E. J., Joles, J. A., & van Raalte, D. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.123 · Cited by 407
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ferrannini, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.011 · Cited by 340
Vasopressin: physiology, assessment and osmosensation
Bankir, L., Bichet, D. G., & Morgenthaler, N. G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12645 · Cited by 266
Self-citationCortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A., & Remuzzi, G. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00559-y · Cited by 214
Metadata
- Authors
- Bankir, L., Roussel, R., & Bouby, N.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2015-07-01
- Volume
- 309
- Issue
- 1
- Pages
- F2-F23
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2123786774
- Cited by
- 111
- References
- 23
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.